Cicada Innovations’ Post

🎉 Exciting news from Assistive Technology Development! They have been awarded $306,872 by the U.S. Department of Health and Human Services (HHS), specifically the National Institutes of Health and the NIH National Institute of Biomedical Imaging and Bioengineering. This funding will support the development of a lightweight robotic telerehabilitation device with integrated blood flow restriction for patients with musculoskeletal conditions. This innovative device aims to reduce recovery costs and improve outcomes for patients undergoing knee surgeries by providing motorized exercise modes and data sharing capabilities. #SBIR #STTR #Innovation 💡 The project will focus on creating a cost-effective device that enhances low-load exercise benefits while reducing clinic visits and supporting patients in rural areas. The research will include pilot usability studies with physical therapists and patients recovering from ligament reconstruction. The award, classified as a project grant, will last for 12 months, starting on September 1, 2024, and ending on August 31, 2025. We can't wait to see the positive impact this technology will have on the healthcare industry! #HealthcareInnovation #Rehabilitation #TechForGood

From advanced imaging to accessible online education, these UK tech companies are redefining industries. Here’s who to watch 👀 🔬 A MedTech innovator advancing diagnostic imaging for ophthalmology. 💊 A groundbreaking approach to antibody discovery, accelerating drug development. 🧪 Rapid point-of-care diagnostics for infection detection. 📷 High-performance imaging tech empowering faster diagnoses for healthcare. 📊 Data-driven insights for the health tech industry. 📚 An all-in-one online tuition platform connecting students and tutors. Siloton | Antiverse | Llusern Scientific | Cirdan Ltd | Signify Research Ltd | Sherpa Online These innovators are setting new standards in tech. Excited to see where they take things next!

I'm thrilled to announce that our paper on "Enhancing Glaucoma Diagnosis Through Image Processing and Supervised Learning" has been successfully presented at the IEEE 11th International Conference on Reliability, Infocom Technologies, and Optimization (ICRITO 2024), hosted by Amity Institute of Information Technology at Amity University Uttar Pradesh, India! The conference brought together experts and researchers from diverse fields to explore the latest advancements in reliability, infocom technologies, and optimization. Our presentation delved into the crucial intersection of healthcare and technology, focusing on the application of image processing techniques and supervised learning algorithms to improve the diagnosis of glaucoma, a leading cause of irreversible blindness worldwide. Early diagnosis is key to preventing vision loss associated with glaucoma, and our research aims to enhance the accuracy and efficiency of glaucoma detection through innovative approaches. By leveraging advanced image analysis methods and machine learning models, we strive to empower healthcare professionals with tools for timely and accurate diagnosis, ultimately improving patient outcomes in ophthalmology. Participating in this conference was an enriching experience, providing valuable insights, feedback, and opportunities for collaboration. I'm grateful for the support of my co-authors and colleagues in advancing research at the forefront of healthcare innovation. You can access it from here:https://lnkd.in/gfkmP3aT #Research #GlaucomaDiagnosis #Healthcare

Prof. Razieh Salahandish is making strides in biomedical device development with funding from the Mitacs Accelerate program! This program gives students hands-on experience, helps them build essential skills through industry-driven research, and connects them with professionals in the field. Alongside Scanbo, a leader in AI-driven medical diagnostics, Prof. Salahandish's team will design and fabricate AI-assisted devices to meet the growing demand for at-home health monitoring systems. These devices make it easier to manage diseases like diabetes, improve treatment results, evaluate disease risk, and track how diseases develop over time. This important step forward in biomedical innovation is set to make a real impact in healthcare and beyond! Learn more about this work: https://bit.ly/4fd4QUU #YUPositiveChange #YUChangeMakers

The energy of investment and innovation was alive and well in Dana Point yesterday at the LSI Emerging Medtech Summit. With a slow return to a more normal flow of deals, a result of $1.2 Trillion in equity available and the 8% profitability growth of market leaders in our segment. This increasing availability of cash and M&A, combined with the innovations being unleashed in Neurology, connectivity, and AI, is creating palpable energy at this meeting. Innovators listening to the advice of Neil Shah and Raymond Cohen, whose successful exits are what all of these innovators are working hard to create. A key takeaway for me is that the expansion of Catheter-based Neurosurgery means that neurology is poised for an explosion of innovation, just like Cardiology and Vascular have been in the last couple of decades. #LSI24

🌟 Empowering Lives Through Innovation in EBME 🌟 This week, we reflect on how every breakthrough in Electro Biomedical Engineering (EBME) not only advances technology but fundamentally enhances health and quality of life. Our quote of the week encapsulates this perfectly: "In EBME, every innovation is a step towards empowering individuals, enhancing both health and quality of life." From developing more intuitive prosthetics to creating smarter monitoring systems, each innovation in EBME is a testament to the power of technology to transform lives. Let's celebrate the incredible progress in this field and continue to support the innovations that bring hope and improved functionality to individuals around the world. What recent innovation in EBME has inspired you? Share your thoughts and join the conversation on how technology is making a real difference in healthcare. #EBME #HealthcareInnovation #BiomedicalEngineering #TechForGood #InnovationInHealthcare #EmpoweringLives #QualityOfLife #nGenium Sam O'Leary Nathan Upton Nathan Read Alan Ling Jowell Grandison

UCD is spearheading a groundbreaking EU project on extracellular vesicles (EVs), aiming to revolutionise biomedical research with early diagnostics and personalised therapies. The EVEREST project unites top academic and industry partners to standardise EV isolation and characterisation, pushing forward non-invasive diagnostic tools and targeted treatments. The EVEREST project, led by UCD, is set to advance extracellular vesicle (EV) research for early diagnostics and personalised medicine. Through broad EU collaboration, it aims to standardise EV techniques, enhancing the precision of treatments for complex diseases. This initiative is poised to set new benchmarks in biomedical innovation, significantly impacting diagnostics and therapies across the industry. Read more: https://lnkd.in/gsW2udxb #ExtracellularVesicles #BiomedicalInnovation #EUResearch #EVEREST #UCDScience #PersonalisedMedicine #HealthcareTech #LifeSciences

🚀 Revolutionary Medical Breakthrough! Researchers at University College London (UCL) have unveiled a cutting-edge miniature scanner that could transform the way we diagnose diseases like cancer, diabetes, and arthritis. This innovative device uses laser light and ultrasound waves to generate real-time, 3D images of the body, offering unprecedented detail without the need for harmful X-rays. What sets this scanner apart is its ability to capture images in under a second, making it faster and more efficient than traditional methods. The technology, known as Photoacoustic Tomography (PAT), could soon be used in handheld devices for routine clinical use, providing safer, more accessible diagnostics for patients. This is a game-changer for medical imaging, allowing healthcare professionals to diagnose and manage conditions with greater accuracy and speed. #HealthcareInnovation #MedicalImaging #UCL #TechnologyInMedicine #FutureOfHealthcare

Riccardo Semadeni and Schlomo Aschkenasy the cofounders of MediRapp AG presented to a distigushed audience of #investors of SICTIC the unique #AI solution for #echocardiography. As of today, MediRapp is a #bootstrapping operation. The founders decided to open the company to #investors. A very smart move. The presentation took palce in #Bern at the Insel Gruppe . MediRapp's system is already in operational usage by leading #cardiologists in #Switzerland. The system is competible with echocardiograms of Philips Siemens Healthineers GE HealthCare Canon Medical Systems Corporation Toshiba America Medical Systems... MediRapp aims to transform the global #ultrasound #diagnostics market with #ai powered digital solutions that boost #workflow efficiency and improve #patient outcomes. Dieudonné Mbarga Goran Lazarov Innosuisse Swissnex ETH Zürich StartAngels Network Business Angels Switzerland American College of Cardiology European Society of Cardiology SwissCardio HPlus

🚀New Grand Solution investment 🚀 We're thrilled to announce a groundbreaking investment by Innovation Fund Denmark, totaling nearly 30 million DKK, in a new pioneering public-private collaboration. The vision? To empower healthcare professionals with real-time insights, enabling proactive intervention and reducing the incidence of complications, ultimately enhancing patient safety in post-operative care and management of acute medical conditions. 🏥 The project will leverage already established technologies and further develop T&W Engineering A/Ss patient-friendly #earEEG monitoring device with new sensors to record vital parameters directly from the ear, coupled with an intelligent interpretation system, the WARD 24/7 WARD-system. 🛡️ Professor Eske Kvanner Aasvang from Rigshospitalet and Professor Christian Meyhoff from Bispebjerg Hospital, the driving forces behind the clinical research, emphasize the importance of continuous monitoring in improving patient outcomes: “With innovative multimodal measurements from the ear, the project aims to enhance the current monitoring systems, providing better insights into patients' physiological status. This advancement is crucial for continuous 24-hour monitoring, especially for vital parameters like blood pressure and oxygen saturation.” The opportunity to develop a new multisensory wearable system in collaboration with leading clinicians, for the benefit of patients and healthcare providers, is exactly what attracts T&W Engineering A/S, Richard Tøpholm, CEO of T&W Engineering A/S, explains. "We want to support the vision of a patient-centric and data driven healthcare system, and we aim to develop technological solutions that can follow the patient from in-hospital to home-use. If we can develop solutions that continuously monitor patients’ vital signs including brain function, we can begin to build up much better health profiles, which is critical to successfully intervening deterioration and preventing harm to patients" he says. This partnership between leading hospitals, WARD 24/7, and T&W Engineering A/S exemplifies the potential of Danish life science to drive advanced healthcare technologies on a global scale. Stay tuned as the project named ONWARD sets out to transform patient monitoring, improve healthcare outcomes, and pave the way for a more patient-centered, data-driven future in healthcare! 💪 #HealthcareInnovation #ONWARD #PatientMonitoring #earEEG #sleep #neuroscience